AstraZeneca Pharma India Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India has received shareholder approval for shifting its registered office from Karnataka to Maharashtra. The special resolution was passed through postal ballot via remote e-voting, with results declared on May 12, 2026. The amendment requires updates to the 2nd clause of the Memorandum of Association. The relocation remains subject to obtaining requisite regulatory approvals under the Companies Act, 2013 and other applicable rules.
This is primarily an administrative relocation that may affect the company's state tax jurisdiction and regulatory filings going forward. No immediate impact on business operations or financial performance is indicated.